Free Trial

Calumet (NASDAQ:CLMT) Stock Price Up 3.8% - What's Next?

Calumet logo with Energy background

Key Points

  • Calumet, Inc. shares rose by 3.8% on Wednesday, trading as high as $20.05, but experienced a decline in trading volume, with only 225,384 shares traded compared to the average of over 1.1 million.
  • Analyst reports varied, with Goldman Sachs raising its price target to $20.00 and a "buy" rating, while Weiss Ratings issued a "sell" rating, and Zacks Research downgraded Calumet to a "strong sell".
  • In its latest quarterly earnings, Calumet reported a loss of ($1.70) earnings per share, missing the consensus estimates by ($1.26), despite revenues exceeding expectations at $1.03 billion.
  • MarketBeat previews the top five stocks to own by November 1st.

Calumet, Inc. (NASDAQ:CLMT - Get Free Report)'s share price rose 3.8% during trading on Wednesday . The company traded as high as $20.05 and last traded at $19.38. Approximately 225,384 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 1,118,982 shares. The stock had previously closed at $18.67.

Analysts Set New Price Targets

CLMT has been the topic of a number of analyst reports. The Goldman Sachs Group lifted their price target on Calumet from $15.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday. Weiss Ratings reissued a "sell (e+)" rating on shares of Calumet in a research note on Wednesday, October 8th. Zacks Research cut Calumet from a "hold" rating to a "strong sell" rating in a research note on Tuesday, October 7th. Finally, UBS Group boosted their target price on Calumet from $12.00 to $13.25 and gave the company a "neutral" rating in a research note on Tuesday, August 12th. Four analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $19.71.

View Our Latest Analysis on CLMT

Calumet Trading Up 3.3%

The stock has a 50 day simple moving average of $17.31 and a 200-day simple moving average of $15.02. The firm has a market capitalization of $1.67 billion, a P/E ratio of -3.69 and a beta of 0.98.

Calumet (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The oil and gas company reported ($1.70) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.44) by ($1.26). The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $982.88 million. The firm's revenue for the quarter was down 9.4% on a year-over-year basis. During the same period in the prior year, the company posted ($0.48) EPS. As a group, sell-side analysts expect that Calumet, Inc. will post -3.02 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Amalgamated Bank purchased a new position in shares of Calumet during the 2nd quarter valued at about $37,000. University of Texas Texas AM Investment Management Co. lifted its position in shares of Calumet by 109.4% during the 2nd quarter. University of Texas Texas AM Investment Management Co. now owns 3,350 shares of the oil and gas company's stock valued at $53,000 after buying an additional 1,750 shares in the last quarter. Ameritas Investment Partners Inc. purchased a new position in shares of Calumet during the 2nd quarter valued at about $111,000. Premier Path Wealth Partners LLC lifted its position in shares of Calumet by 11.4% during the 2nd quarter. Premier Path Wealth Partners LLC now owns 12,853 shares of the oil and gas company's stock valued at $202,000 after buying an additional 1,320 shares in the last quarter. Finally, SP Asset Management LLC purchased a new position in shares of Calumet during the 2nd quarter valued at about $205,000. 34.41% of the stock is owned by hedge funds and other institutional investors.

Calumet Company Profile

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Calumet Right Now?

Before you consider Calumet, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.

While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.